A Role for TNF Receptor Type II in Leukocyte Infiltration into the Lung during Experimental Idiopathic Pneumonia Syndrome

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 4, 2008, Pages 385-396

  Hildebrandt, Gerhard C ^a,b   Olkiewicz, Krystyna M ^a   Corrion, Leigh ^a   Clouthier, Shawn G ^a   Pierce, Elizabeth M ^c   Liu, Chen ^d   Cooke, Kenneth R ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Bone Marrow Transplant Program   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokines; Graft versus host disease; Stem cell transplantation; TNF

Indexed keywords

CD8 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; IDIOPATHIC DISEASE; LEUKOCYTE; LUNG BLOOD VESSEL; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; VASCULAR ENDOTHELIUM;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; LUNG; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; PNEUMONIA; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; STEM CELL TRANSPLANTATION; SYNDROME; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40649127479     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.01.004     Document Type: Article

References (72)

1. Clark J., Hansen J., Hertz M., Parkman R., Jensen L., and Peavy H. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 147 (1993) 1601-1606
2. Crawford S., Longton G., and Storb R. Acute graft versus host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 12 (1993) 225
3. Kantrow S.P., Hackman R.C., Boeckh M., Myerson D., and Crawford S.W. Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation 63 (1997) 1079-1086
4. Weiner R.S., Mortimer M.B., Gale R.P., et al. Interstitial pneumonitis after bone marrow transplantation. Ann Intern Med 104 (1986) 168-175
5. Yanik G., Hellerstedt B., Custer J., et al. Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 8 (2002) 395-400
6. Fukuda T., Hackman R.C., Guthrie K.A., et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 102 (2003) 2777-2785
7. Wingard J.R., Mellits E.D., Sostrin M.B., et al. Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution. Medicine 67 (1988) 175-186
8. Weiner R.S., Horowitz M.M., Gale R.P., et al. Risk factors for interstitial pneumonitis following bone marrow transplantation for severe aplastic anemia. Br J Haematol 71 (1989) 535
9. Della Volpe A., Ferreri A.J., Annaloro C., et al. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. Int J Radiat Oncol Biol Phys 52 (2002) 483-488
10. Cooke K.R., Krenger W., Hill G.R., et al. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood 92 (1998) 2571-2580
11. Clark J.G., Madtes D.K., Hackman R.C., Chen W., Cheever M.A., and Martin P.J. Lung injury induced by alloreactive Th1 cells is characterized by host-derived mononuclear cell inflammation and activation of alveolar macrophages. J Immunol 161 (1998) 1913-1920
12. Panoskaltsis-Mortari A., Taylor P.A., Yaegar T.M., et al. The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogenic recipients are due to donor T cell infusion and potentiated by cyclophosphamide. J Clinl Invest 100 (1997) 1015-1027
13. Panoskaltsis-Mortari A., Hermanson J.R., Haddad I.Y., Wangensteen O.D., and Blazar B.R. Intercellular adhesion molecule-I (ICAM-I, CD54) deficiency segregates the unique pathophysiological requirements for generating idiopathic pneumonia syndrome (IPS) versus graft-versus-host disease following allogeneic murine bone marrow transplantation. Biol Blood Marrow Transplant 7 (2001) 368-377
14. Cooke K.R., Hill G.R., Gerbitz A., et al. Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation 70 (2000) 272-279
15. Cooke K.R., Hill G.R., Gerbitz A., et al. Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammation. J Immunol 165 (2000) 6612-6619
16. Piguet P.F., Grau G.E., Collart M.A., Vassalli P., and Kapanci Y. Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor MRNA and chronic interstitial pneumonitis. Lab Invest 61 (1989) 37-45
17. Holler E., Kolb H.J., Moller A., et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 75 (1990) 1011-1016
18. Clark J.G., Madtes D.K., Martin T.R., Hackman R.C., Farrand A.L., and Crawford S.W. Idiopathic pneumonia after bone marrow transplantation: cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment. Crit Care Med 27 (1999) 1800-1806
19. Clark J.G., Mandac J.B., Dixon A.E., Martin P.J., Hackman R.C., and Madtes D.K. Neutralization of tumor necrosis factor-alpha action delays but does not prevent lung injury induced by alloreactive T helper 1 cells. Transplantation 70 (2000) 39-43
20. Hildebrandt G.C., Olkiewicz K.M., Corrion L.A., et al. Donor-derived TNF-alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood 104 (2004) 586-593
21. Brockhaus M., Schoenfeld H.J., Schlaeger E.J., Hunziker W., Lesslauer W., and Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87 (1990) 3127-3131
22. Loetscher H., Pan Y.C., Lahm H.W., et al. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61 (1990) 351-359
23. Lewis M., Tartaglia L.A., Lee A., et al. Cloning and expression of cDNAs for two distinct tumor necrosis factor receptors demonstrate on receptor is species-specific. Proc Natl Acad Sci USA 88 (1991) 2830
24. Schall T.J., Lewis M., Koller K.J., et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61 (1990) 361-370
25. Kalthoff H., Roeder C., Brockhaus M., Thiele H.G., and Schmiegel W. Tumor necrosis factor (TNF) up-regulates the expression of p75 but not p55 TNF receptors, and both receptors mediate, independently of each other, up-regulation of transforming growth factor alpha and epidermal growth factor receptor mRNA. J Biol Chem 268 (1993) 2762-2766
26. Winzen R., Wallach D., Kemper O., Resch K., and Holtmann H. Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J Immunol 150 (1993) 4346-4353
27. Tannenbaum C.S., Major J.A., and Hamilton T.A. IFN-gamma and lipopolysaccharide differentially modulate expression of tumor necrosis factor receptor mRNA in murine peritoneal macrophages. J Immunol 151 (1993) 6833-6839
28. Beutler B., and van Huffel C. Unraveling function in the TNF ligand and receptor families. Science 264 (1994) 667-668
29. Bazzoni F., and Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 334 (1996) 1717-1725
30. Tartaglia L.A., Ayres T.M., Wong G.H., and Goeddel D.V. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74 (1993) 845-853
31. Tartaglia L.A., Rothe M., Hu Y.F., and Goeddel D.V. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73 (1993) 213-216
32. Peschon J.J., Torrance D.S., Stocking K.L., et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 160 (1998) 943-952
33. Pfeffer K., Matsuyama T., Kundig T.M., et al. Mice deficient for the 55kD tumor necrosis factor receptor are resistant to endotoxin shock, yet succumb to L. monocytogenes infection. Cell 73 (1993) 457
34. Grell M., Wajant H., Zimmermann G., and Scheurich P. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc Natl Acad Sci USA 95 (1998) 570-575
35. Rothe J., Mackay F., Bluethmann H., Zinkernagel R., and Lesslauer W. Phenotypic analysis of TNFR1-deficient mice and characterization of TNFR1-deficient fibroblasts in vitro. Circ Shock 44 (1994) 51-56
36. Sheehan K.C., Pinckard J.K., Arthur C.D., Dehner L.P., Goeddel D.V., and Schreiber R.D. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75. J Exp Med 181 (1995) 607-617
37. Hill G.R., Teshima T., Rebel V.I., et al. The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity. J Immunol 164 (2000) 656-663
38. Brown G.R., and Thiele D.L. Enhancement of MHC class I-stimulated alloresponses by TNF/TNF receptor (TNFR)1 interactions and of MHC class II-stimulated alloresponses by TNF/TNFR2 interactions. Eur J Immunol 30 (2000) 2900-2907
39. Speiser D.E., Bachmann M.F., Frick T.W., et al. TNF receptor p55 controls early acute graft-versus-host disease. J Immunol 158 (1997) 5185-5190
40. Shukla M., Yang S., Milla C., Panoskaltsis-Mortari A., Blazar B.R., and Haddad I.Y. Absence of host tumor necrosis factor receptor 1 attenuates manifestations of idiopathic pneumonia syndrome. Am J Physiol Lung Cell Mol Physiol 288 (2005) L942-L949
41. Song Y., Ao L., Raeburn C.D., et al. A low level of TNF-alpha mediates hemorrhage-induced acute lung injury via p55 TNF receptor. Am J Physiol Lung Cell Mol Physiol 281 (2001) L677-L684
42. Erickson S., de Sauvage F., Kikly K., et al. Decreased sensitivity to tumour-necrosis factor but normal T-cell develpment in TNF receptor-2-deficient mice. Nature 372 (1994) 560-563
43. Grau G.E., Mili N., Lou J.N., et al. Phenotypic and functional analysis of pulmonary microvascular endothelial cells from patients with acute respiratory distress syndrome. Lab Invest 74 (1996) 761-770
44. Lucas R., Lou J., Morel D.R., Ricou B., Suter P.M., and Grau G.E. TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria. J Leukoc Biol 61 (1997) 551-558
45. Ortiz L., Lasky J., Lungarella G., et al. Upregulation of the p75 but not the p55 TNFα receptor mRNA after Silica and Bleomycin exposure and protectin from lung injury in double receptor knockout mice. Am J Respir Cell Mol Biol 20 (1999) 825-833
46. Cooke K.R., Kobzik L., Martin T.R., et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin. Blood 88 (1996) 3230-3239
47. Yousem S.A. The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol 26 (1995) 668-675
48. Sloane J., Depledge M., Powles R., Morgenstern G., Trickey B., and Dady P. Histopathology of the lung after bone marrow transplantation. J Clin Pathol 36 (1983) 546-554
49. Beschorner W., Saral R., Hutchins G., Tutschka P., and Santos G. Lymphocytic bronchitis associated with graft versus host disease in recipients of bone marrow transplants. N Engl J Med 299 (1978) 1030-1036
50. Cooke K.R., Krenger W., Hill G., et al. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood 92 (1998) 2571-2580
51. Pasparakis M., Alexopoulou L., Episkopou V., and Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184 (1996) 1397-1411
52. Cooke K., Gerbitz A., Hill G., et al. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 107 (2001) 1581-1589
53. Hill G., and Ferrara J. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 95 (2000) 2754-2759
54. Nestel F.P., Price K.S., Seemayer T.A., and Lapp W.S. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med 175 (1992) 405-413
55. Schmaltz C., Alpdogan O., Muriglan S.J., et al. Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. Blood 101 (2003) 2440-2445
56. Gerbitz A., Ewing P., Olkiewicz K., et al. A role for CD54 (intercellular adhesion molecule-1) in leukocyte recruitment to the lung during the development of experimental idiopathic pneumonia syndrome. Transplantation 79 (2005) 536-542
57. Panoskaltsis-Mortari A., Strieter R.M., Hermanson J.R., et al. Induction of monocyte- and T-cell-attracting chemokines in the lung during the generation of idiopathic pneumonia syndrome following allogeneic murine bone marrow transplantation. Blood 96 (2000) 834-839
58. Hildebrandt G.C., Duffner U.A., Olkiewicz K.M., et al. A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood 103 (2004) 2417-2426
59. Hildebrandt G.C., Olkiewicz K.M., Choi S., et al. Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation. Blood 105 (2005) 2249-2257
60. Hildebrandt G.C., Corrion L.A., Olkiewicz K.M., et al. Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome. J Immunol 173 (2004) 2050-2059
61. Grell M., Douni E., Wajant H., et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83 (1995) 793-802
62. Monastra G., Cabrelle A., Zambon A., et al. Membrane form of TNF alpha induces both cell lysis and apoptosis in susceptible target cells. Cell Immunol 171 (1996) 102-110
63. Hauber H.P., Mikkila A., Erich J.M., et al. TNFalpha, interleukin-10 and interleukin-18 expression in cells of the bronchoalveolar lavage in patients with pulmonary complications following bone marrow or peripheral stem cell transplantation: a preliminary study. Bone Marrow Transplant 30 (2002) 485-490
64. Weiss T., Grell M., Hessabi B., et al. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site. J Immunol 158 (1997) 2398-2404
65. Tartaglia L.A., Pennica D., and Goeddel D.V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268 (1993) 18542-18548
66. Bigda J., Beletsky I., Brakebusch C., et al. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J Exp Med 180 (1994) 445-460
67. Grell M., Zimmermann G., Gottfried E., et al. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 18 (1999) 3034-3043
68. Grell M., Zimmermann G., Hulser D., Pfizenmaier K., and Scheurich P. TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J Immunol 153 (1994) 1963-1972
69. Hamilton B.L. L3T4-positive T cells participate in the induction of graft-versus-host disease in response to minor histocompatibility antigens. J Immunol 139 (1987) 2511-2515
70. Kinkhabwala M., Sehajpal P., Skolnik E., et al. A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells. J Exp Med 171 (1990) 941-946
71. Zhao M.Q., Stoler M.H., Liu A.N., et al. Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition. J Clin Invest 106 (2000) R49-R58
72. Liu A.N., Mohammed A.Z., Rice W.R., et al. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand. Am J Respir Cell Mol Biol 20 (1999) 849-858